vancomycin has been researched along with ceragenin csa-13 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Faull, KF; Ghali, S; Jacobs, JP; Koon, HW; Lagishetty, V; Lee, EC; Moller, T; Mussatto, CC; Ortiz, C; Rossetti, M; Tran, DH; Wang, J; Xu, C | 1 |
1 other study(ies) available for vancomycin and ceragenin csa-13
| Article | Year |
|---|---|
Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
Topics: Animals; Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Gastrointestinal Microbiome; Intestines; Mice; Mice, Inbred C57BL; Steroids; Vancomycin | 2018 |